(Q28193430)

English

Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences

scientific article (publication date: 10 August 2002)

In more languages

Statements

scholarly article

0 references

Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences (English)

0 references

0 references

0 references

author name string

Caroline Kamate

1

0 references

Samia Baloul

2

0 references

Sabine Grootenboer

3

0 references

Eric Pessis

4

0 references

Alain Chevrot

5

0 references

Micheline Tulliez

6

0 references

Carmen Marchiol

7

0 references

Mireille Viguier

8

0 references

Didier Fradelizi

9

0 references

language of work or name

0 references

publication date

10 August 2002

0 references

International Journal of Cancer

0 references

100

0 references

5

0 references

571-9

0 references

Murine mast cell lines as indicators of early events in mast cell and basophil development

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Sequential measurement of the murine acute-phase protein serum amyloid P component (SAP) as an indicator of graft-versus-host disease following allogeneic bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Inhibition of tumor growth by elimination of granulocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Expression of cyclooxygenase-2 in prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Is cyclooxygenase-2 the alpha and the omega in cancer?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Tumor rejection by disturbing tumor stroma cell interactions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

ONCOGENESIS: Landscaping the Cancer Terrain

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10519

21 January 2018

Identifiers

10.1002/IJC.10519

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28193430&oldid=986452347"